|
Frederick CW Wu

Achievements:
Medical Research Council Clinical Training Fellow with Professor D.T. Baird C.B.E., Department of Obstetrics and Gynaecology, University of Edinburgh - Aug 1977 - July 1979
Member of the Steering Committee, Task Force on the Regulation of Male Fertility, World Health Organisation Special Programme of Research, Development and Research Teaching in Human Reproduction since 1992 – present
President, European Academy of Andrology - December 2006 - present
Chairman of Examination Committee for the Diploma for Clinical Andrology, European Academy of Andrology 1997 –2006.
Treasurer, International Society of Andrology from 1994 - 2001
Member of the Executive Council, European Academy of Andrology 1997 to present.
Treasurer, International Society of Andrology from 1994 - 1997 and 1997 - 2001 (second term).
Selected current grants:
European Commission Framework Programme V – European Male Ageing Study: Prevalence, incidence and geographical distribution of symptoms of ageing in men and their endocrine, genetic and psychosocial correlated. €6,100,000 over 7.5 years from January 2002. Forty percent of this grant is awarded to the University of Manchester. January 2002 - March 2009.
Organon International bv - A phase IIb open-label trial investigating the efficacy, safety and pharmacokinetics of subcutaneous ORG3236 rods combined with intramuscular testosterone undecaoate for male contraception. £133,478 over two years. Started October 2003, completed 2006.
Effects of testosterone on muscle function, physical performance, body composition and quality of life in frail elderly men, Schering AG - £659,390 over 3 years - with J Oldham and M Connolly. September 2004 – August 2007
The human serum metabolome in health and disease, BBSRC-LINK Applied Genomics Programme Grant - £3.9 million over 4 years with D Kell, G Goodacre, JK Cruickshank, N Purandare, A Burns, G Jayson, Astra-Zeneca and GSK. January 2005 – December 2009
World Health Organisation – Sperm suppression and contraceptive protection provided by norethisterone-enanthate plus testosterone undecanoate in normal men £270,000 over three years (to commence in Jan 2008 – Jan 2011)
CURRICULUM VITAE - Frederick CW Wu

|